Ronald T Ackermann1,2,3, Matthew J O'Brien4,5,6. 1. Department of Medicine, Division of General Internal Medicine and Geriatrics, Northwestern University Feinberg School of Medicine, 750 N. Lake Shore Drive, 10th Floor, Chicago, IL, 60611, USA. r.ackermann@northwestern.edu. 2. Institute for Public Health and Medicine, Northwestern University Feinberg School of Medicine, 750 N. Lake Shore Drive, 6th Floor, Chicago, IL, 60611, USA. r.ackermann@northwestern.edu. 3. Center for Diabetes and Metabolism, Northwestern University Feinberg School of Medicine, 300 E Superior St #15-703, Chicago, IL, 60611, USA. r.ackermann@northwestern.edu. 4. Department of Medicine, Division of General Internal Medicine and Geriatrics, Northwestern University Feinberg School of Medicine, 750 N. Lake Shore Drive, 10th Floor, Chicago, IL, 60611, USA. 5. Institute for Public Health and Medicine, Northwestern University Feinberg School of Medicine, 750 N. Lake Shore Drive, 6th Floor, Chicago, IL, 60611, USA. 6. Center for Diabetes and Metabolism, Northwestern University Feinberg School of Medicine, 300 E Superior St #15-703, Chicago, IL, 60611, USA.
Abstract
PURPOSE OF REVIEW: Type 2 diabetes is common, burdensome, and preventable. Landmark trials such as the Diabetes Prevention Program (DPP) demonstrated that resource-intensive lifestyle support interventions resulting in modest weight loss via healthy diet changes and physical activity can lower the rate of diabetes development by 58%. We performed a review of efforts to translate and implement DPP-like programs throughout the USA to identify challenges and opportunities for improvement. RECENT FINDINGS: For more than a decade, multiple stakeholders have worked to translate evidence-based principles of diabetes prevention to reach 84 million Americans with prediabetes. DPP-like programs have been delivered by over 1500 organizations, reaching almost 300,000 people, but this number represents less than 1% of the target population. Research has uncovered large gaps in efforts to diagnose, raise awareness, and provide access to DPP-like programs for adults with prediabetes, requiring further stakeholder engagement and coordination to resolve. Efforts to address prevailing gaps in diabetes prevention must address distinct and sometimes conflicting priorities and concerns of stakeholders. Our review recommends several areas of further research and action to improve type 2 diabetes prevention on a population scale.
PURPOSE OF REVIEW: Type 2 diabetes is common, burdensome, and preventable. Landmark trials such as the Diabetes Prevention Program (DPP) demonstrated that resource-intensive lifestyle support interventions resulting in modest weight loss via healthy diet changes and physical activity can lower the rate of diabetes development by 58%. We performed a review of efforts to translate and implement DPP-like programs throughout the USA to identify challenges and opportunities for improvement. RECENT FINDINGS: For more than a decade, multiple stakeholders have worked to translate evidence-based principles of diabetes prevention to reach 84 million Americans with prediabetes. DPP-like programs have been delivered by over 1500 organizations, reaching almost 300,000 people, but this number represents less than 1% of the target population. Research has uncovered large gaps in efforts to diagnose, raise awareness, and provide access to DPP-like programs for adults with prediabetes, requiring further stakeholder engagement and coordination to resolve. Efforts to address prevailing gaps in diabetes prevention must address distinct and sometimes conflicting priorities and concerns of stakeholders. Our review recommends several areas of further research and action to improve type 2 diabetes prevention on a population scale.
Entities:
Keywords:
Diabetes prevention; Dissemination of evidence; Implementation challenges; Prediabetes; Type 2 diabetes
Authors: Aviva H Ariel-Donges; Eliza L Gordon; Brittney N Dixon; Abraham J Eastman; Viviana Bauman; Kathryn M Ross; Michael G Perri Journal: Transl Behav Med Date: 2020-12-31 Impact factor: 3.046
Authors: Robert Ratner; Ronald Goldberg; Steven Haffner; Santica Marcovina; Trevor Orchard; Sarah Fowler; Marinella Temprosa Journal: Diabetes Care Date: 2005-04 Impact factor: 19.112
Authors: Anjali Gopalan; Ilona S Lorincz; Christopher Wirtalla; Steven C Marcus; Judith A Long Journal: Am J Prev Med Date: 2015-06-16 Impact factor: 5.043
Authors: William H Hernan; Michael Brandle; Ping Zhang; David F Williamson; Margaret J Matulik; Robert E Ratner; John M Lachin; Michael M Engelgau Journal: Diabetes Care Date: 2003-01 Impact factor: 19.112
Authors: Matthew J O'Brien; Ji Young Lee; Mercedes R Carnethon; Ronald T Ackermann; Maria C Vargas; Andrew Hamilton; Nivedita Mohanty; Sarah S Rittner; Jessica N Park; Amro Hassan; David R Buchanan; Lei Liu; Joseph Feinglass Journal: PLoS Med Date: 2016-07-12 Impact factor: 11.069
Authors: Mohammed K Ali; Kai McKeever Bullard; Giuseppina Imperatore; Stephen R Benoit; Deborah B Rolka; Ann L Albright; Edward W Gregg Journal: JAMA Netw Open Date: 2019-05-03
Authors: Uma Mudaliar; Azadeh Zabetian; Michael Goodman; Justin B Echouffo-Tcheugui; Ann L Albright; Edward W Gregg; Mohammed K Ali Journal: PLoS Med Date: 2016-07-26 Impact factor: 11.069
Authors: Stephanie L Fitzpatrick; Meghan Mayhew; Chris L Catlin; Alison Firemark; Inga Gruß; Denis B Nyongesa; Maureen O'Keeffe-Rosetti; Andreea M Rawlings; David H Smith; Ning Smith; Victor J Stevens; William M Vollmer; Stephen P Fortmann Journal: Perm J Date: 2021-12-13
Authors: Kimberly R Azelton; Aidan P Crowley; Nicholas Vence; Karin Underwood; Gerald Morris; John Kelly; Matthew J Landry Journal: Front Digit Health Date: 2021-11-25
Authors: Bryan Gibson; Sara Simonsen; Leah Yingling; Julia Schaefer; Yue Zhang; Roger Altizer; Jakob D Jensen; Vishnu Sundaresh Journal: JMIR Diabetes Date: 2022-03-17